Treatment-emergent adverse events (≥ 10%).
| Adverse Events | Patients, n (%) |
|---|---|
| Noninfectious adverse events | |
| Any event excluding injection site reactions | 75 (93) |
| Injection site reaction | 30 (37) |
| Headache | 16 (20) |
| Abdominal pain | 14 (17) |
| Diarrhea | 12 (15) |
| Accidental injury | 11 (14) |
| Rhinitis | 11 (14) |
| Asthenia | 10 (12) |
| Back pain | 10 (12) |
| Hemorrhage | 9 (11) |
| Arthralgia | 9 (11) |
| Cough increased | 9 (11) |
| Pain | 8 (10) |
| Nausea | 8 (10) |
| Infectious event | |
| Any infectious event | 71 (88) |
| Upper respiratory tract infection | 43 (53) |
| Flu syndrome | 22 (27) |
| Skin infections | 19 (24) |
| Pharyngitis or laryngitis | 15 (19) |
| Infectious diarrhea | 11 (14) |